|Year : 2015 | Volume
| Issue : 5 | Page : 377-382
|Determination of normal range for fasting salivary glucose in Type 1 diabetics
Karandeep Singh Arora1, Nagesh Binjoo2, G V. Ramachandra Reddy3, Prabhpreet Kaur4, Richa Modgil1, Lalit Singh Negi5
1 Department of Oral Medicine and Radiology, Daswani Dental College and Research Centre, Kota, Rajasthan, India
2 Department of Oral Medicine and Radiology, Dr. BR Ambedkar Institute of Dental Sciences and Hospital, Patna, Bihar, India
3 Department of Oral Medicine and Radiology, Rajasthan Dental College and Hospital, Jaipur, India
4 Department of Oral and Maxillofacial Pathology, BRS Dental College and General Hospital, Panchkula, Haryana, India
5 Department of Oral Medicine and Radiology, Surendra Dental College and Research Institute, Sriganganagar, Rajasthan, India
|Date of Web Publication||22-Sep-2015|
Department of Oral and Maxillofacial Pathology, BRS Dental College and General Hospital, Panchkula - 134 118, Haryana
Source of Support: Nil., Conflict of Interest: There are no conflicts of interest.
| Abstract|| |
Background: The most commonly employed investigative procedure for monitoring glucose levels is blood investigation, which is invasive and gives discomfort to the patient. The purpose of the study was to validate a noninvasive, easy, and reliable method for predicting glucose levels in Type 1 diabetics and to validate a regression equation for converting the known values of salivary glucose to blood glucose. Materials and Methods: 200 volunteers consisting of 100 Type 1 diabetics and 100 healthy controls were included, and their fasting blood and salivary glucose levels were assessed, using a semi-auto analyzer. Results: On analysis of the data, statistically significant positive results were obtained (P < 0.05) when the blood and salivary glucose levels were considered among the study group participants, control group participants, and both study and control group participants. A cut-off value for salivary glucose (11.60 mg%) was defined, above which a person may be considered as diabetic. Also, the regression equation was obtained which could be used for the converson of known value of salivary glucose to blood glucose and vice versa. Conclusion: The present study successfully demonstrated the role of saliva as a noninvasive and reliable marker for the prediction of glucose levels in Type 1 diabetics who show elevated blood glucose levels.
Keywords: Blood glucose, diabetes mellitus, monitoring therapy, noninvasive, salivary glucose
|How to cite this article:|
Arora KS, Binjoo N, Ramachandra Reddy G V, Kaur P, Modgil R, Negi LS. Determination of normal range for fasting salivary glucose in Type 1 diabetics. J Int Soc Prevent Communit Dent 2015;5:377-82
|How to cite this URL:|
Arora KS, Binjoo N, Ramachandra Reddy G V, Kaur P, Modgil R, Negi LS. Determination of normal range for fasting salivary glucose in Type 1 diabetics. J Int Soc Prevent Communit Dent [serial online] 2015 [cited 2019 Jul 19];5:377-82. Available from: http://www.jispcd.org/text.asp?2015/5/5/377/165923
| Introduction|| |
The first complete clinical description of diabetes appears to have been made by Aulus Cornelius Celsus (30 BC–50 AD).
According to the American Diabetes Association, diabetes mellitus has been classified on the basis of etiology into Type 1 and Type 2, other specific types (which include genetic defects in β-cells, genetic defect in insulin action, diseases of the exocrine pancreas, endocrinopathies, drug or chemical induced, infections, uncommon form of immune-mediated diabetes, other genetic syndromes sometimes associated with diabetes), and gestational diabetes mellitus.
Type 1 diabetes accounts for 5–10% of all cases. It results from a progressive, cellular-mediated autoimmune destruction of the pancreatic β-cells that leads to complete insulin deficiency. Patients with Type 1 diabetes are severely insulin deficient and are dependent on insulin treatment for their survival.
In 2000, the estimated global prevalence of diabetes among adults was 2.8%, or 171 million people. The prevalence of diabetes is expected to increase to 4.4%, or 366 million people, by 2030 globally. In India, it is estimated that presently 19.4 million individuals are affected with this deadly disease, and the number is likely to go up to 57.2 million by the year 2056.
The most commonly employed investigative procedure to diagnose diabetes mellitus is blood investigation which is invasive and offer discomfort to patients. Efforts are on, to derive methods which are noninvasive and cause less discomfort to patients. Saliva offers distinctive advantage as it can be collected noninvasively and with limited training, involves fewer complications, and is cost effective. It is beautifully said by Mandel that 'saliva lacks the drama of blood, sincerity of sweat and emotional appearance of tears'. Saliva acts as a mirror of the body and, hence, is a perfect medium to be explored for disease and health surveillance. Considering the ease, painless procedure, and noninvasiveness of collecting salivary samples, and also the limited amount of studies that evaluated the concentration of glucose in saliva, this study was undertaken to authenticate the reliability of saliva as a biomarker for the prediction of glucose levels in Type 1 diabetes.
| Materials and Methods|| |
A total of 200 subjects from the OPD of Department of Oral Medicine and Radiology were included in the study, after obtaining prior approval from the ethical committee of the college [Table 1]. Of these, 100 subjects formed the study group who had a positive history of Type 1 diabetes and were on insulin, but were free from any other systemic illness, were not on medications causing xerostomia, did not have any other obvious oral lesion, were not previously treated for any salivary gland disorder, and were not having any habit of tobacco chewing or smoking.
The analysis of glucose was done using GOD/POD (glucose oxidase-peroxidase) method, which is based on the principle that glucose is oxidized to gluconic acid and hydrogen peroxide in the presence of glucose oxidase. Hydrogen peroxide further reacts with phenol and 4-aminoantipyrine by the catalytic action of peroxidase to form a red-colored quinoneimine dye complex.
Sampling of blood
Fasting blood glucose sample was taken between 8am and 10am. Subjects were given prior instructions to remain on empty stomach. Two milliliters of blood was drawn from the median vein and was allowed to clot in the test tube. Afterward, it was centrifuged at 3000 rpm for 10 min and then the serum was separated. In another test tube, 10 µl of the serum was taken to which 1000 µl of the glucose reagent was added (provided by the manufacturer). This mixture was incubated (in-built in the semi-auto analyzer) for 10 min at 37°C.
Sampling of saliva
Immediately after collecting the blood glucose sample, the fasting saliva sample was taken. The subject was asked to rinse mouth thoroughly to remove any debris. Then he/she was instructed to keep his mouth open for 2–3 min and the saliva was allowed to pool on the floor of mouth. Unstimulated whole saliva was collected in a sterile container by asking the subject to expectorate the saliva into the container gradually over a period of 5–10 min till approximately 1 ml of saliva was collected. The salivary sample collected was then transferred to a test tube and subjected to centrifugation at 3000 rpm for 2–3 min. Afterward, in a fresh test tube, 10 µl of the saliva was taken to which 1000 µl of glucose reagent was added (provided by the manufacturer). This mixture was incubated (in-built in the semi-auto analyzer) for 10 min at 37°C.
Quantitative measurement of blood and salivary glucose was performed using a semi-auto analyzer [Evolution 3000 By Tulip Diagnostics (P) Ltd, Jaipur, India]. The incubated samples of serum and saliva were analyzed separately. The serum and salivary samples were not preserved, but were directly subject to centrifugation, then incubation, and then glucose analysis without any delay.
For the blood and salivary glucose of both the groups, mean and standard deviation were calculated. To check for the statistical significance, z-test was employed which gave a value of P < 0.05, that was considered statistically significant for both the study and control groups separately and also when both the groups were considered together. Furthermore, Pearson's correlation was established for the same parameters which came out to be highly significant. Then, linear regression analysis was done between the blood and salivary glucose of the study group and a regression equation was derived. All the statistical analyses were performed using SPSS v16.0 software.
| Results|| |
The minimum, maximum, mean, and standard deviation of the blood and salivary glucose values obtained [Table 2]. The statistical values obtained for the comparison of study, control group and inter group comparison is being presented in [Table 3].
|Table 2: Minimum, maximum, mean, and standard deviation of the blood and salivary glucose values|
Click here to view
Linear regression equation
Linear regression analysis was determined between the blood and salivary glucose levels among the study group and the R-squared (R2) value obtained was 0.995 [Graph 1]. Further, a regression equation was derived as y = 9.875x + 4.937 [blood glucose = 9.875 (salivary glucose) +4.937] using which a known value of salivary glucose can be converted to blood glucose and vice versa.
Furthermore, a cut-off value of salivary glucose levels was determined for detecting diabetes mellitus. It was observed that with the salivary glucose level greater than 11.60 mg%, the patient is considered as diabetic. Also, the normal range for salivary glucose levels is between 7.60 mg% and 11.60 mg%.
| Discussion|| |
The salivary glucose levels likely follow a threshold mechanism. Diabetes mellitus is a heterogeneous metabolic disease characterized by abnormally elevated blood glucose levels. The increase in salivary glucose levels with increase in blood glucose levels has been suggested to be attributed to "leakage" across the basement membrane of the glands.
Whole saliva is frequently studied as an alternative for blood and can be useful for diagnostic purpose. It contains locally produced substances as well as blood components that can be used for diagnosing a variety of systemic diseases and understanding of their oral manifestations.,
In the present study, for the 200 subjects in the study and control group, correlation was evaluated between the blood and salivary glucose values, which on analysis revealed Pearson's correlation of 0.998 and a P value of <0.01, which was statistically significant.
In a study conducted by Darwazeh et al., statistically significant results were obtained between the blood and the salivary glucose levels when whole saliva was taken into consideration, which are very much similar to the results of our present study.
Jurysta et al. conducted a study considering five sets of experiments which consisted of different groups of individuals and different methods of analysis of the glucose levels in blood and saliva. They reported that the salivary glucose concentration increased as the blood glucose levels started increasing, which is in accordance with the findings of the present study. Ivanovski et al. conducted a study among xerostomic diabetic patients and concluded that there was statistically significant correlation between the blood and salivary glucose levels even if the patient had xerostomia, which is a complication of diabetes.
In the studies carried out by Abikshyeet et al., Panchbhai et al., and Agrawal et al., there was statistically significant correlation between blood and salivary glucose levels when the control group and study group were considered together. In all these studies, the blood and salivary glucose were assessed by glucose oxidase method. The results of all these authors are in accordance with the results of our study.
Statistically non-significant correlations between blood and salivary glucose in the study and control groups were obtained by Tenovuo et al., Aryeh et al., and Vaziri et al., when similar methods for the analysis of blood and salivary glucose were adopted. This variation in result might have been because of the small sample size.
Among the 100 study group subjects, correlation was determined between the blood and salivary glucose values, which on analysis revealed Pearson's correlation value of 0.997. The P value was <0.01, which was statistically significant.
A study conducted by Twetman et al. and Belazi et al. among children with Type 1 diabetes showed a statistically significant correlation between the blood and the salivary glucose levels, which is in accordance with the present study results.
Results obtained in a study conducted by Gough et al. and Guilbault et al. were statistically significant, which showed a good correlation between the levels of blood and salivary glucose on using a chromatographic separation method for carbohydrate analysis biosensors respectively, which is in accordance with our present study results.
Andersson et al. conducted a study taking into consideration the parotid saliva, which showed a statistically significant result and correlation on comparison of the salivary and the blood glucose levels, and the results are similar to that of the present study. Studies conducted by Shehla et al., Bernardi et al., and Shashikumar et al. showed a statistically significant correlation between the salivary and the blood glucose levels, which is accordance with our present study.
The results obtained for blood and salivary glucose levels for the diabetic subjects in the present study are in accordance with the results of a study that was carried out by Lasisi et al. who considered diabetes and periodontitis and concluded that there is statistically high correlation between the blood and salivary glucose levels irrespective of the periodontal condition of the patient. When a similar kind of study was carried out by Forbat et al., it revealed a non-significant correlation of blood glucose and salivary glucose levels among the diabetic patients, which is in disagreement with our study. This difference might be because of the different methods used for the analysis of blood and salivary glucose levels and also due to the small sample size.
Among the 100 subjects of the control group, correlation was determined between the blood and salivary glucose levels, which on analysis revealed Pearson's correlation value of 0.999. The P value was <0.001, which was statistically significant.
The above results obtained for the non-diabetic subjects are in accordance with the results of studies conducted by Abikshyeet et al., Panchbhai et al., and Agrawal et al. and the same evaluation mismatched with the study that was conducted by Darwazeh et al. which suggested a non-significant correlation between the salivary and blood glucose of control group.
In our study, a cut-off value of salivary glucose levels was estimated for determining diabetes mellitus. It was observed that if the salivary glucose is greater than 11.6 mg%, the patient is considered as diabetic and the normal range of salivary glucose levels is 7.60–11.6 mg%. Also, blood glucose can be predicted for a given salivary glucose level by using the regression equation, i.e. [blood glucose = 9.875 (salivary glucose) +4.937]. The R2 value obtained using linear regression analysis is 0.995, which is a highly significant.
A similar short study was conducted by Nagalaxmi et al. who gave a salivary glucose value of 11.5 mg%, which indicated that above this value, a person may be considered diabetic; this is almost equivalent to the value obtained in our present study.
The statistical correlation in this study has proved that salivary glucose can be used as an indicator for the presence of diabetes, which has an advantage of being a noninvasive method.
Thus, based on the results of the present study, it can be concluded that salivary glucose levels do serve as a reliable indicator of blood glucose levels in the diabetic patients with elevated blood glucose levels.
In the present study, saliva seemed to play a very useful role as a noninvasive method of diabetes monitoring. But further studies need to be undertaken involving other methods to estimate salivary glucose levels, preferably the digital methods, and compare the postprandial and random blood glucose levels and salivary glucose levels, to find the effects of any other systemic disease on the levels of salivary glucose in diabetic patients, and check the effect of use of tobacco products on the salivary glucose levels, to authenticate the role of saliva as a noninvasive method of salivary glucose estimation.
We are thankful to the Department of Oral and Maxillofacial Pathology, Rajasthan Dental College and Hospital, Jaipur for the clinical investigation of blood and salivary glucose.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Zajac J, Shrestha A, Patel P, Poretsky L. The main events in the history of diabetes mellitus. In: Poretsky L, editor. Principles of Diabetes Mellitus. New York: Springer; 2009. p. 3-18.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetic Care 2010;33(Suppl 1):S62-9.
Streckfus CF, Bigler LR. Saliva as a diagnostic fluid. Oral Dis 2002;8:69-76.
Leu JP, Zonszein J. Diagnostic criteria and classification of diabetes. In: Poretsky L, editor. Principles of Diabetes Mellitus. New York: Springer; 2009. p. 107-16.
Chamany S, Tabaei BP. Epidemiology. In: Poretsky L, editor. Principles of Diabetes Mellitus. New York: Springer; 2009. p. 117-28.
Pradeeepa R, Deepa R, Mohan V. Epidemiology of diabetes in India-Current perspective and future projections. J Indian Med Assoc 2002;100:144-8.
Chan AY, Swaminathan R, Cockram CS. Effectiveness if sodium fluoride as a preservative of glucose in blood. Clin Chem 1989;35:315-7.
Mandel ID. The diagnostic uses of saliva. J Oral Pathol Med 1990;19:199-25.
Khalil OS. Spectroscopic and clinical aspects of noninvasive glucose measurements. Clin Chem. 1999;45:165-77.
Mealey B. Diabetes mellitus and endocrine diseases. In: Burket's Oral Medicine. 11th
ed. Hamilton: BC Decker Inc.; 2008. p. 509-10.
Sashikumar R, Kannan R. Salivary glucose levels and oral candidal carriage in type II diabetics. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;109:706-11.
Kaufman E, Lamster IB. The diagnostic applications of saliva- A review. Crit Rev Oral Biol Med 2002;13:197-212.
Soares MS, Batista-Filho MM, Pimentel MJ, Passos IA, Chimenos-Küstner E. Determination of salivary glucose in healthy adults. Med Oral Patol Oral Cir Bucal 2009;14:e510-3.
Darwazeh AM, MacFarlane TW, Mac Cuish AC, Lamey PJ. Mixed salivary glucose levels and candidal carriage in patients with diabetes mellitus. J Oral Pathol Med 1991;20:280-3.
Jurysta C, Bulur N, Oguzhan B, Satman I, Yilmaz TM, Malaisse WJ, et al
. Salivary glucose concentration and excretion in normal and diabetic subjects. J Biomed Biotechnol 2009;2009:430426.
Ivanovski K, Naumovski V, Kostadinova M, Pesevska S, Drijanska K, Filipce V. Xerostomia and salivary levels of glucose and urea in patients with diabetes. Prilozi 2012;33:219-29.
Abikshyeet P, Ramesh V, Oza N. Glucose estimation in the salivary secretion of diabetes mellitus patients. Diabetes Metab Syndr Obes 2012;5:149-54.
Panchbhai AS. Correlation of salivary glucose level with blood glucose level in diabetes mellitus. J Oral Maxillofac Res 2012;3:e3.
Agrawal RP, Sharma N, Rathore MS, Gupta VB, Jain S, Agarwal V, et al
. Noninvasive method for glucose level estimation by saliva. J Diabetes Metab 2013;4:1-5.
Tenovuo J, Alanen P, Larjava H, Viikari J, Lehtonen OP. Oral health of patients with insulin-dependent diabetes mellitus. Scand J Dent Res 1986;94:338-46.
Aryeh HB, Cohen M, Kanter MD, Szargel R and Laufer D. Salivary composition in diabetic patients. J Diabetes Complications. 1988;2:96-9.
Vaziri PB, Vahedi M, Mortazavi H, Hajilooi AM. Evaluation of Salivary Glucose, IgA and Flow Rate in Diabetic Patients: A Case-Control Study. Journal of Dentistry, Tehran University of Medical Sciences, Tehran, Iran 2010;7:13-8.
Twetman S, Nederfors T, Stahl B, Aronson S. Two - year longitudinal observations of salivary status and in children with indulin-dependent diabetes mellitus. Pediatric Dentistry 1992;14:184-8.
Belazi MA, Galli-Tsinopoulou A, Drakoulakos D, Fleva A, Papanayiotou PH. Salivary alterations in insulin-dependent diabetes mellitus. Int J Paediatr Dent 1998;8:29-33.
Gough H, Luke GA, Beeley JA and Geddes DAM. Human Salivary Glucose Analysis By High-Performance Ion-Exchange Chroiviatography And Pulsed Amperometric Detection. Archs Oral Biol 1996;41:141-5.
Guilbault GG, Palleschi G. Non-invasive biosensors in clinical analysis. Biosens Bioelectron 1995;10:379-92.
Andersson AB, Birkhed D, Berntorp K, Lindgarde F
and Matsson L. Glucose concentration in parotid saliva after glucose/food intake in individuals with glucose intolerance and diabetes mellitus. Eur J Oral Sci 1998;106:931-7.
Bernardi MJ, Reis A, Loguercio AD, Kehrig R, Leite MF, Nicholau J. Study of the Buffering Capacity, pH and Salivary Flow Rate in Type 2 Well-Controlled and Poorly Controlled Diabetic Patients. Oral Health Prev Dent 2007;5:73-8.
Lasisi TJ, Fasanmade AA. Comparative Analysis of Salivary Glucose And Electrolytes In Diabetic Individuals With Periodontitis. Ann Ibd Pg Med 2012;10:25-30.
Forbat LN, Collins RE, Maskell GK and Sonksen PH. Glucose concentrations in parotid fluid and venous blood of patients attending a diabetic clinic. J Royal Soc Med 1981;74:1-4.
Nagalaxmi V, Priyanka V. Can Saliva be a Marker for Predicting Type - 1 Diabetes Mellitus? - A Pilot Study. J Ind Acad Oral Med Radiol 2011;23:579-82.
[Table 1], [Table 2], [Table 3]
|This article has been cited by|
||Accuracy of salivary glucose assessment in diagnosis of diabetes and prediabestes
| ||Samar Fares,Marwa Sayed Mohamed Said,Walaa Ibrahim,Tarek T. Amin,Nagwa Eid Sobhy Saad |
| ||Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019; 13(2): 1543 |
|[Pubmed] | [DOI]|
||An On-Chip Disposable Salivary Glucose Sensor for Diabetes Control
| ||Yunqing Du,Wenjun Zhang,Ming L. Wang |
| ||Journal of Diabetes Science and Technology. 2016; 10(6): 1344 |
|[Pubmed] | [DOI]|
||Therapeutic traps in management of diabulimia in acute setting: A case report
| ||Reza Mafi,Assif Naqvi,Julia Jeschke,Katarzyna Kucharska |
| ||Postepy Psychiatrii i Neurologii. 2016; |
|[Pubmed] | [DOI]|
| Article Access Statistics|
| Viewed||2018 |
| Printed||29 |
| Emailed||0 |
| PDF Downloaded||136 |
| Comments ||[Add] |
| Cited by others ||3 |